 |
PDBsum entry 2c6u
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
The crystal structure and mutational binding analysis of the extracellular domain of the platelet-Activating receptor clec-2.
|
 |
|
Authors
|
 |
A.A.Watson,
J.Brown,
K.Harlos,
J.A.Eble,
T.S.Walter,
C.A.O'Callaghan.
|
 |
|
Ref.
|
 |
J Biol Chem, 2007,
282,
3165-3172.
|
 |
|
PubMed id
|
 |
|
 |
|
Note: In the PDB file this reference is
annotated as "TO BE PUBLISHED". The citation details given above have
been manually determined.
|
 |
 |
|
Abstract
|
 |
|
The human C-type lectin-like molecule CLEC-2 is expressed on the surface of
platelets and signaling through CLEC-2 causes platelet activation and
aggregation. CLEC-2 is a receptor for the platelet-aggregating snake venom
protein rhodocytin. It is also a newly identified co-receptor for human
immunodeficiency virus type 1 (HIV-1). An endogenous ligand has not yet been
identified. We have solved the crystal structure of the extracellular domain of
CLEC-2 to 1.6-A resolution, and identified the key structural features involved
in ligand binding. A semi-helical loop region and flanking residues dominate the
surface that is available for ligand binding. The precise distribution of
hydrophobic and electrostatic features in this loop will determine the nature of
any endogenous ligand with which it can interact. Major ligand-induced
conformational change in CLEC-2 is unlikely as its overall fold is compact and
robust. However, ligand binding could induce a tilt of a 3-10 helical portion of
the long loop region. Mutational analysis and surface plasmon resonance binding
studies support these observations. This study provides a framework for
understanding the effects of rhodocytin venom binding on CLEC-2 and for
understanding the nature of likely endogenous ligands and will provide a basis
for rational design of drugs to block ligand binding.
|
 |
|
|
|
|
 |